deltatrials
Unknown NCT05051423

Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer (THERRES)

Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer

Sponsor: Institutul Clinic Fundeni

Conditions Gastric Cancer
Updated 5 times since 2021 Last updated: Sep 24, 2021 Started: Nov 1, 2019 Primary completion: Jan 31, 2022 Completion: Jan 31, 2022

Listed as NCT05051423, this observational or N/A phase trial focuses on Gastric Cancer and remains ongoing. Sponsored by Institutul Clinic Fundeni, it has been updated 5 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Oct 2023 · 22 months · monthly snapshotRecruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 19 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  3. Oct 2023 — Jul 2024 [monthly]

    Unknown Status

    Status: RecruitingUnknown Status

  4. Dec 2021 — Oct 2023 [monthly]

    Recruiting

  5. Oct 2021 — Dec 2021 [monthly]

    Recruiting

    First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institutul Clinic Fundeni
  • University of Medicine and Pharmacy Craiova
Data source: University of Medicine and Pharmacy Craiova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations